Status: Recruiting
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
This is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).
Participants needed: 78
Trial details
Phase: Phase 2Age: 25-100Biological sex: FemaleType: InterventionalSponsor: Frantz Viral Therapeutics, LLCUpdated: Oct 2, 2025Locations: 7
Eligibility criteria
Adult females age ≥ 25 years [+5]
Pregnant and nursing women [+6]